Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Panacela Labs logo — Fostering biomedical breakthroughs for oncology and rare dis...

Panacela Labs

Fostering biomedical breakthroughs for oncology and rare diseases through global collaboration

Founded 2011 3 employees Series B Total: $39.90M Biotechnology, Health Care

General Information

Company Name Panacela Labs
Founded Year 2011
Founders / Decision Makers
Team member
Employees 3
Industries Biotechnology, Health Care
Funding Stage Series B
Social

BounceWatch is an independent company data service, not affiliated with Panacela Labs. To contact Panacela Labs, visit panacelalabs.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Panacela Labs compare?

A PDF of Panacela Labs and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Panacela Labs soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Panacela Labs

Panacela Labs is a collaborative enterprise fostering biomedical breakthroughs for oncology and rare diseases through global collaboration. Founded in 2011 by Cleveland BioLabs (Nasdaq:CBLI), a clinical-stage biotechnology company specializing in oncology and orphan drug development, and Open Joint Stock Company “RUSNANO,” the largest Russian investment entity, in partnership with Roswell Park Cancer Institute, Children’s Cancer Institute of Australia, and Cleveland Clinic Foundation. Cleveland BioLabs holds a 54.6% ownership stake in Panacela Labs. The company is located within the Innovation Center "Skolkovo." Their most recent investment was a $2.90M Series B investment on 24 December 2015 from Cleveland BioLabs and RUSNANO. Panacela Labs operates in the Biotechnology and Health Care sectors, positioning itself at the intersection of cutting-edge science and investment opportunities.

Business keywords: biomedical breakthroughs, oncology, rare diseases, clinical-stage biotechnology, orphan drug development, global collaboration, investment, joint venture, innovation center, Skolkovo, partnerships, cancer research, Russian investment, ownership stake

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Series B $2.90M 2
Cleveland BioLabs, RUSNANO
24 Dec 2015
Series A $37.00M 2
Cleveland BioLabs, RUSNANO
07 Oct 2011

Panacela Labs Alternatives & Competitors

View All Alternatives
Panacela Labs vs
Cleveland Biolabs
Cleveland Biolabs United States

Cleveland BioLabs, Inc. (Nasdaq:CBLI) is a clinical-stage biotechnology company with a focus on onco...

Post-IPO Equity
21 employees
Biotechnology, Health Care
Panacela Labs vs
Forma Therapeutics
Forma Therapeutics United States

Dedicated to transforming the lives of patients with rare hematologic diseases and cancers.

Series D
159 employees
Biotechnology, Health Care
Panacela Labs vs
Phoenix Molecular Designs
Phoenix Molecular Designs United States

A clinical stage biopharmaceutical company designing precise cancer therapeutics to address unmet me...

Series A
22 employees
Biotechnology, Health Care
View all alternatives

FAQ About Panacela Labs

Fostering biomedical breakthroughs for oncology and rare diseases through global collaboration
Panacela Labs was founded in 2011.
Panacela Labs operates in Biotechnology and Health Care. Its work centres on biomedical breakthroughs, oncology, rare diseases and clinical-stage biotechnology.
Panacela Labs has approximately 3 employees.
Panacela Labs has completed 2 funding rounds, raising a total of $39.90M. The latest funding stage is Series B.
Top alternatives and competitors to Panacela Labs include Cleveland Biolabs, Forma Therapeutics, Phoenix Molecular Designs, Relay Therapeutics, Onena Medicines. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Panacela Labs and Cleveland Biolabs are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Panacela Labs, https://bouncewatch.com/company/panacela-labs, updated 14 January 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout